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Abstract Niemann–Pick disease, a neurovisceral lyso-
somal lipid storage disorder, is a rare disorder that is
unknown to many clinicians. The disease, that often has its
onset during childhood or adolescence, shows a polymor-
phic clinical picture, including psychiatric symptoms.
Because of its infrequence, Niemann–Pick disease is diag-
nosed with an average delay of 6 years. This report presents
a case of an adolescent male whose symptoms had led to
various hospitalisations and psychiatric diagnoses. When he
presented with psychotic symptoms in our department,
thorough diagnosis revealed Niemann–Pick disease type C1
as the underlying disease.
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Introduction
Niemann–Pick disease type C (NPC), first described by
Niemann in 1914 [6] and characterized with its pathology
by Pick in 1933 [9], is a fatal neurovisceral lysosomal lipid
storage disorder of autosomal recessive inheritance with a
birth prevalence of 1:100,000 live births. Biochemically
and phenotypically, it is different from Niemann–Pick
diseases types A and B, which are characterized by lyso-
somal sphingomyelinase deficiency. On a cellular level,
NPC is characterized by accumulation of unesterified
cholesterol and glycolipids in the endosomal/lysosomal
system [7], due to an inactivating mutation of NPC1 pro-
tein, which normally aids movement of unesterified
cholesterol from the endosomal/lysosomal compartment to
the cytosolic compartment. The symptomatology, which
generally encompasses hepatosplenomegaly, cerebellar
ataxia, dysarthria, vertical gaze palsy, cognitive difficulties
and progressive neurological deterioration, is polymorphic
with various epiphanies and great variety in the progress [2,
10]. NPC is difficult to diagnose, particularly when it
presents as a pure psychiatric disorder [1, 4, 10].
Psychiatric signs associated with NPC may remain iso-
lated for several years and are usually consistent with
psychotic symptoms (e.g. paranoid delusions, auditory or
visual hallucinations, interpretative thoughts) and behav-
ioural disturbances like aggressiveness, self-mutilation or
social isolation [10].
Presently, the treatment of NPC is restricted to
symptomatic measures. Causal therapeutic approaches,
which include substrate reduction therapy [8], reversal
of lysosomal transport [5] or stem cell transplantation
(e.g. NCT00176904, http://clinicaltrials.gov, accessed
31.01.2009), are still in a pre-clinical stage or limited to
small preliminary trials.
Case report
We present the case of a 17-year-old male, who was
admitted to our child and adolescent psychiatric ward with
the diagnosis of paranoid schizophrenia. Under treatment
with quetiapine (1,000 mg/d, no side effects), he still suf-
fered from productive symptoms such as auditory and
visual hallucinations and content-thought disorders.
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Interestingly, the patient had a long history of physical
and psychiatric problems. The first medical conspicuity
was neonatal jaundice. His motor development was
delayed; he had difficulties to tie his shoes and to use zips.
Language acquisition was significantly late. A speech
therapy at 3 years of age was discontinued as it showed no
effect. Later on, behavioural disturbances were noticed,
including a tendency towards social isolation, stereotypic
occupations, obsessive-compulsive practices as well as
aggressive tendencies.
At the age of 7, the patient temporarily experienced
auditory hallucinations. At the age of 8 he was presented to
a child and adolescent psychiatrist for the first time, due to
substantial learning difficulties and emotional problems. A
HAWIK-R intelligence test revealed a result in the lower
average range. Additionally, the diagnosis of an isolated
reading and writing disorder was made. Simultaneously, a
splenomegaly was diagnosed, which was considered to
be a persistent splenomegaly after an Epstein–Barr virus
infection.
At the age of 13, an absence epilepsy (abnormal EEG
and observation of absences with fixed gaze and lack of
response for a 2-year period) was diagnosed and success-
fully treated with valproic acid.
As symptoms persisted, at the age of 14 years the
patient was referred to a social paediatric center where a
pervasive development disorder was diagnosed based upon
significant results in specific autism tests [Autism Diag-
nostic Interview Revised (ADI-R) and Autism Diagnostic
Observation Schedule-Generics (ADOS-G)]. Additionally,
due to recurrent headaches with vomiting, infantile
migraine was diagnosed. Besides significantly impaired
motor functions, the patient also presented a mild dysdi-
adochokinesia and slurred speech. A genetic analysis for
fragile X syndrome and chromosomal abnormalities and a
subtelomere screening were carried out, showing no path-
ological results.
At the age of 16, emergency hospitalisation was necessary
after 2 months of increasing content-thought abnormality,
including paranoia, visual and auditory hallucinations. Fur-
thermore, formal-thought disorders, disorientation to all
qualities, a labile affect and an abnormal gait were present.
After 4 months of antipsychotic treatment with risperidone
(2.5 mg/d, no side effects reported), visual and auditory
hallucinations ceased and orientation recovered. The patient
was discharged with the diagnoses of a transient psychotic
episode and Asperger’s syndrome.
Three months later, the then 17-year-old adolescent was
admitted to the child and adolescent psychiatric department
again. This time, he presented with symptoms of temporal
disorientation, content- and formal-thought disorders,
significant dysmnesia, impaired concentration and dysar-
thria. Additionally, he showed stand and gait ataxia.
Subsequently, antipsychotic therapy was switched from
risperidone to quetiapine (final dose: 1,000 mg/d, no side
effects). Under this treatment, psychotic symptoms
improved and the patient was discharged with the diag-
noses of paranoid schizophrenia and Asperger’s syndrome.
Subsequently, due to the above-reported motor and
coordinative abnormalities and dysarthria, he was pre-
sented to a neuropediatric outpatient clinic, where the
suspected diagnosis of a cerebellar disorder was made. A
cerebral MRI showed no pathologies at this time.
About 1 month later, the patient was admitted to our
child and adolescent psychiatry ward for comprehensive
diagnostic analysis. Due to the neurological abnormalities
mentioned before, the patient was sent to the neuropedi-
atric department for a diagnostic investigation with the
suspicion of an organic psychosis. The neurological
examination revealed ataxia, dysarthria, mild dysdiado-
chokinesia, inability to stand up from lying without
bracing, a mild paresis of the peroneal nerve, slightly
reduced motor strength, particularly broadened reflex zones
and a strong rebound phenomenon. Vertical gaze palsy, a
characteristic diagnostic sign in the majority of NPC
patients, was not present. The physical examination
revealed the already known splenomegaly. Under the sus-
pected diagnosis of Niemann–Pick disease, a fibroblast
culture was installed, which showed positive filipin stain-
ing, thus proving the diagnosis. Further molecular genetic
testing revealed two mutations in exons 13 and 19 of the
NPC1 gene on chromosome 18q, confirming Niemann–
Pick disease subtype C1.
During the stay on our ward, the patient developed
paranoia and aggressive impulses against other patients.
For this reason, the antipsychotic treatment with quetiapine
(1,000 mg/d) was augmented with haloperidol (10 mg/d)
in combination with biperiden (4 mg/d), resulting in a
considerable improvement of psychopathology and disap-
pearance of productive psychotic symptoms. Side effects
were not reported. Unfortunately, during the course of his
hospital stay, the patient’s physical health deteriorated
significantly; the maximum walking distance decreased to
200 m and he had to use a wheelchair for longer distances.
After 4 months of inpatient treatment, the patient was
discharged to an institution for children and adolescents
with chronic physical and mental health problems.
Discussion
Because of its infrequency, NPC is diagnosed with an
average delay of 6.2 (±6.4) years [10]. Our case demon-
strates that, particularly when associated with psychiatric
symptoms, the course towards a correct diagnosis may
take even longer. Furthermore, accompanying unspecific
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symptoms like learning difficulties may also lead to
misdiagnoses.
Admittedly, the association of psychiatric symptoms and
NPC does not necessarily establish a causal link between
both entities. However, when taking into account the
considerable rates of psychiatric symptoms (general psy-
chiatric symptoms in early adulthood in 38% of patients
[10], history of psychotic symptoms in 35% of young adult
patients [3]) described in case series of NPC patients, in the
above-reported case a causal relationship between NPC
and psychotic symptoms appears most likely.
In conclusion, in patients with psychotic symptoms and
especially in those with additional motor and cognitive
impairments, every child and adolescent psychiatrist
should be aware of the possibility of an organic psychosis.
In those cases, a thorough differential diagnostic and
assessment, including also quite infrequent disorders, is of
utmost importance [11].
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